Jazz Pharmaceuticals to Present New Data Highlighting Advancements in Rare Blood Cancers at ASH 2023
DUBLIN, Nov. 30, 2023 - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present six abstracts related to LLS TAP-supported Vyxeos (CPX-351) at the 65th Annual American Society of Hematology (ASH) Annual Meeting from December 9-12.
Vyxeos Presentations
|
Presentation Title |
Author |
Presentation Details |
|
Population Pharmacokinetic-Pharmacodynamic Modeling of Neutrophil and Platelet Count for Lower-Intensity Therapy of CPX-351 Combined With Venetoclax in Acute Myeloid Leukemia |
Yali Liang, et al. |
Type: Poster Number: 2902 Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II Date/Time: Sunday, December 10, 6:00-8:00 PM |
|
CPX-351 With Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase Ib Study |
Alex Bataller, et al. |
Type: Poster Number: 4259 Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III Date/Time: Monday, December 11, 6:00-8:00 PM |
|
Phase 2 Study of CPX-351 in Combination with Venetoclax in Patients with Newly Diagnosed, High Risk Acute Myeloid Leukemia |
Wei-Ying Jen, et al. |
Type: Poster Number: 4273 Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III Date/Time: Monday, December 11, 6:00-8:00 PM |
|
Results of a Phase 1/2 Study of Lower Dose CPX-351 for Patients with Int-2 or High Risk IPSS Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia after Failure to Hypomethylating Agents |
Guillermo Montalban-Bravo, et al. |
Type: Poster Number: 1873 Session: 637. Myelodysplastic Syndromes Clinical and Epidemiological: Poster I Date/Time: Saturday, Dec. 9, 5:30 PM-7:30 PM |
|
CRISPR/Cas9 Screen Identifies CPX-351 and 7+3 Regimens Response Modulators with Distinct Sensitive and Resistant Profiles [IST] |
Nam Nguyen, et al. |
Type: Poster Number: 1412 Session: 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I Date/Time: Saturday, Dec. 9, 5:30-7:30 PM |
|
CPX-351 in Patients with Newly Diagnosed Post Myeloproliferative Neoplasms Acute Myeloid Leukemia [IST] |
Sylvain Garciaz, et al. |
Type: Poster Number: 2917 Session: 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II Date/Time: Sunday, Dec. 10, 6:00-8:00 PM |